drugset / Trial / NCT00828295
Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The objective of the study is to assess the safety and efficacy of two doses of IV palonosetron each administered as a single dose for the prevention of postoperative nausea and vomiting through 72 hours postoperatively in children aged 28 days up to 16 years inclusive undergoing surgical procedures requiring general endotracheal inhalation anesthesia.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-12
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palonosetron | Other / unclassified | 1 ug/kg | Intravenous |
| Subject | Palonosetron | Other / unclassified | 3 ug/kg | Intravenous |
Indications
No indication recorded.